Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. In late stages, all signs of right heart failure are added, from which patients typically die.
Autoren
- Dr. med. Yaosi Li
- Dr. med. Daniel Grund
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Artificial intelligence
Dr. ChatGPT: Large language models in everyday clinical practice
- Focus on prevention
Colorectal cancer screening – an update
- COPD therapy
Drug therapy – Update 2025
- From symptom to diagnosis
Oncology – Thymoma
- Shared decision making
Participatory decision-making using the example of diets for type 1 diabetes
- Patient-centered rounds in medicine
Aligning care with the patient
- Migraine and vascular regulation
CGRP-targeted migraine therapies for vascular risk patients
- Chronic and acute coronary syndrome